FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387251004: Haloprogin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461429017 Haloprogin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481353019 Haloprogin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
815721000172110 haloprogine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Haloprogin (substance) Is a Skin antifungal agent false Inferred relationship Some
Haloprogin (substance) Is a classe d'allergènes false Inferred relationship Some
Haloprogin (substance) Is a allergène médicamenteux false Inferred relationship Some
Haloprogin (substance) Is a Antifungal true Inferred relationship Some
Haloprogin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antifungal true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Haloprogin 1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Haloprogin (substance) Inferred relationship Some
Haloprogin 10 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Haloprogin (substance) Inferred relationship Some
Product containing haloprogin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Haloprogin (substance) Inferred relationship Some 1
Product containing haloprogin in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Haloprogin (substance) Inferred relationship Some
Product containing precisely haloprogin 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Haloprogin (substance) Inferred relationship Some
Haloprogin-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Haloprogin (substance) Inferred relationship Some 1
Haloprogin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Haloprogin (substance) Inferred relationship Some 1
Haloprogin only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Haloprogin (substance) Inferred relationship Some 1
Haloprogin 10 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Haloprogin (substance) Inferred relationship Some 1
Haloprogin 10 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Haloprogin (substance) Inferred relationship Some 1
Product containing precisely haloprogin 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Haloprogin (substance) Inferred relationship Some 1
Product containing precisely haloprogin 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Haloprogin (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start